2 active not recruiting, 1 completed, 1 enrolling by invitation, 1 recruiting. 4 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 1, Completed 1, Enrolling by invitation 1, Recruiting 1 |
| Phase 3 | 2 | Active not recruiting 1, Withdrawn 1 |
Follow Vera Therapeutics, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atacicept in Multiple Glomerular Diseases Atacicept - pMN, IgAN | Phase 2 | Recruiting | Vera Therapeutics, Inc. | 250 | 2025-07-07 | 2026-06-26 |
| Monthly Dosing of Atacicept in IgAN Atacicept - IgA Nephropathy (IgAN), Berger Disease | Phase 2 | Active not recruiting | Vera Therapeutics, Inc. | 90 | 2025-05-29 | 2026-04-13 |
| A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept Atacicept 150 mg - IgA Nephropathy (IgAN), Renal and Urinary Disorders | Phase 2 | Enrolling by invitation | Vera Therapeutics, Inc. | 750 | 2024-12-01 | 2026-06-22 |
| Atacicept in Subjects With IgA Nephropathy Atacicept, Placebo to match Atacicept - IgA Nephropathy, Berger Disease | Phase 3 | Active not recruiting | Vera Therapeutics, Inc. | 428 | 2023-06-29 | 2026-10-01 |
| Atacicept in Subjects With Active Lupus Nephritis (COMPASS) Atacicept, Placebo - Lupus Nephritis (LN) | Phase 3 | Withdrawn | Vera Therapeutics, Inc. | 2022-11-02 | 2025-05-23 | |
| A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients MAU868, Placebo - BK Virus Infection | Phase 2 | Completed | Vera Therapeutics, Inc. | 30 | 2020-08-05 | 2023-06-07 |
Glomerulonephritis, IGA (4) · Autoimmune Diseases (1) · Glomerulonephritis (1) · Immune System Diseases (1) · Kidney Diseases (1) · Lupus Erythematosus, Systemic (1) · Lupus Nephritis (1) · Macular dystrophy, corneal type 1 (1) · Nephritis (1) · Nephrotic Syndrome (1) · Urologic Diseases (1)
TACI receptor-IgG Fc fragment fusion protein (5)
United States (6) · Canada (1) · Puerto Rico (1) · Spain (1)
Eric Michael, MD (2) · Joanne Curley (1) · Pam Winterberg (1) · Zeeshan Khawaja (1)
PMID 39352862, PMID 39382091, PMID 39462308, PMID 41196369, PMID 41620980